BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33798832)

  • 21. A laboratory strategy for genotyping haemoglobin H disease in the Chinese.
    Chan AY; So CC; Ma ES; Chan LC
    J Clin Pathol; 2007 Aug; 60(8):931-4. PubMed ID: 17018682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Hb H disease genotypes common in northern Thailand by quantitative real-time polymerase chain reaction and high resolution melting analyses.
    Seeratanachot T; Sanguansermsri T; Shimbhu D
    Hemoglobin; 2013; 37(6):574-83. PubMed ID: 23957826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curative Stem Cell Transplantation for Severe Hb H Disease Manifesting From Early Infancy: Phenotypic and Genotypic Analyses.
    Surapolchai P; Sirachainan N; So CC; Hongeng S; Pakakasama S; Anurathapan U; Chuansumrit A
    Hemoglobin; 2016; 40(1):70-3. PubMed ID: 26575104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of Coexistence of β-Thalassemia Minor in Hb H Disease Patients.
    Chen GL; Jiang F; Li J; Zhou JY; Li DZ
    Hemoglobin; 2018; 42(5-6):306-309. PubMed ID: 30614310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare Hb H disease due to the - -(SEA) and 16.6 kb α-thalassemia-2 deletions.
    Sroymora S; Jindadamrongwech S; Butthep P; Chuncharunee S
    Hemoglobin; 2012; 36(2):200-4. PubMed ID: 22376301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity scoring system to guide transfusion management in pediatric non-deletional HbH.
    Songdej D; Tandhansakul M; Wongwerawattanakoon P; Sirachainan N; Charoenkwan P; Chuansumrit A
    Pediatr Int; 2023; 65(1):e15568. PubMed ID: 37475523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical phenotypes and molecular characterization of Hb H-Paksé disease.
    Viprakasit V; Tanphaichitr VS; Pung-Amritt P; Petrarat S; Suwantol L; Fisher C; Higgs DR
    Haematologica; 2002 Feb; 87(2):117-25. PubMed ID: 11836160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Novel Nonsense Mutation in a Patient with Transfusion-Dependent Hb H Disease.
    Holtkamp N; Pistioli A; Rasenack T; Kiesewetter H; Heinze KG
    Clin Lab; 2018 Mar; 64(3):371-374. PubMed ID: 29739111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex interaction of Hb Hekinan [alpha27(B8) Glu-Asp] and Hb E [beta26(B8) Glu-Lys] with a deletional alpha-thalassemia 1 in a Thai family.
    Fucharoen S; Changtrakun Y; Ratanasiri T; Fucharoen G; Sanchaisuriya K
    Eur J Haematol; 2003 May; 70(5):304-9. PubMed ID: 12694166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran.
    Hamid M; Keikhaei B; Galehdari H; Saberi A; Sedaghat A; Shariati G; Mohammadi-Anaei M
    Sci Rep; 2022 Mar; 12(1):4856. PubMed ID: 35319015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin H identification by high-performance liquid chromatography in confirmed hemoglobin H disease.
    Turley E; McFarlane A; Halchuk L; Verhovsek M
    Int J Lab Hematol; 2015 Oct; 37(5):668-72. PubMed ID: 25989219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hb H disease genotypes in Southern China.
    Fang J; Chen L; Zeng R; Tian Q; Jiang W; Li H; Chen Z; Du C; Chen S
    Hemoglobin; 2014; 38(1):76-8. PubMed ID: 24261598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic variability in a chinese family with nondeletional Hb H-Hb Quong Sze disease.
    Li J; Liao C; Zhou JY; Xie XM; Li R; Chen LH; Li DZ
    Hemoglobin; 2011; 35(4):430-3. PubMed ID: 21797711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
    Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
    Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hb H disease: clinical course and disease modifiers.
    Fucharoen S; Viprakasit V
    Hematology Am Soc Hematol Educ Program; 2009; ():26-34. PubMed ID: 20008179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A newly modified hemoglobin H inclusion test as a secondary screening for α(0)-thalassemia in Southeast Asian populations.
    Fucharoen G; Yooyen K; Chaibunruang A; Fucharoen S
    Acta Haematol; 2014; 132(1):10-4. PubMed ID: 24356175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and molecular analysis of Hb H disease in Taiwan.
    Chao YH; Wu KH; Wu HP; Liu SC; Peng CT; Lee MS
    Biomed Res Int; 2014; 2014():271070. PubMed ID: 25309906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and accurate quantitation of Hb Bart's and Hb H using weak cation exchange high performance liquid chromatography: correlation with the alpha-thalassemia genotype.
    Papassotiriou I; Traeger-Synodinos J; Vlachou C; Karagiorga M; Metaxotou A; Kanavakis E; Stamoulakatou A
    Hemoglobin; 1999 Aug; 23(3):203-11. PubMed ID: 10490132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of uncommon deletions in alpha-thalassemia using the pcr-reverse dot-blot method for prenatal diagnosis of nondeletional hemoglobin H disease.
    Yang Y; Li DZ
    Acta Haematol; 2010; 124(1):9-12. PubMed ID: 20516677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hb H disease with various β hemoglobinopathies: molecular, hematological and diagnostic aspects.
    Fucharoen S; Fucharoen G
    Hemoglobin; 2012; 36(1):18-24. PubMed ID: 22145566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.